Item 9 Labs Corp. – OTC:INLB
Item 9 Labs Corp. stock price today
Item 9 Labs Corp. stock price monthly change
Item 9 Labs Corp. stock price quarterly change
Item 9 Labs Corp. stock price yearly change
Item 9 Labs Corp. key metrics
Market Cap | 17.40M |
Enterprise value | 39.80M |
P/E | -0.36 |
EV/Sales | 1.93 |
EV/EBITDA | -1.77 |
Price/Sales | 0.35 |
Price/Book | 0.11 |
PEG ratio | N/A |
EPS | -0.34 |
Revenue | 19.61M |
EBITDA | -22.05M |
Income | -33.27M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -150.94% |
Oper. margin | -109.43% |
Gross margin | 36.62% |
EBIT margin | -109.43% |
EBITDA margin | -112.4% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeItem 9 Labs Corp. stock price history
Item 9 Labs Corp. stock forecast
Item 9 Labs Corp. financial statements
| Jun 2022 | 4.93M | -5.47M | -110.93% |
|---|---|---|---|
| Sep 2022 | 4.00M | -18.48M | -461.92% |
| Mar 2023 | 5.66M | -3.40M | -60.16% |
| Jun 2023 | 5.02M | -5.91M | -117.7% |
| 2023-02-14 | -0.03 | -0.03 |
|---|
| Sep 2022 | 110761619 | 48.82M | 44.08% |
|---|---|---|---|
| Dec 2022 | 114670232 | 54.31M | 47.36% |
| Mar 2023 | 114126644 | 56.44M | 49.46% |
| Jun 2023 | 112015496 | 59.37M | 53% |
| Jun 2022 | -2.38M | 242.95K | 2.48M |
|---|---|---|---|
| Sep 2022 | -238.21K | -1.39M | 1.27M |
| Mar 2023 | 302.58K | 1.49K | -224.71K |
| Jun 2023 | 150.13K | -62.84K | -5.01K |
Item 9 Labs Corp. alternative data
| Aug 2023 | 97 |
|---|---|
| Sep 2023 | 97 |
| Oct 2023 | 97 |
| Nov 2023 | 97 |
| Dec 2023 | 97 |
| Jan 2024 | 97 |
| Feb 2024 | 97 |
| Mar 2024 | 97 |
| Apr 2024 | 97 |
| May 2024 | 97 |
| Jun 2024 | 97 |
| Jul 2024 | 97 |
Item 9 Labs Corp. other data
| Period | Buy | Sel |
|---|---|---|
| Oct 2013 | 1000 | 0 |
| May 2014 | 42500 | 0 |
| Aug 2014 | 5523 | 0 |
| Quarter | Transcript |
|---|---|
| Q3 2022 16 Aug 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 16 May 2022 | Q2 2022 Earnings Call Transcript |
| Q1 2022 15 Feb 2022 | Q1 2022 Earnings Call Transcript |
| Q4 2021 18 Jan 2022 | Q4 2021 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Jeffrey I. Rassas (1963) Chief Strategy Officer & Director | $196,700 |
Mr. Andrew Douglas Bowden (1988) Chief Executive Officer & Director | $169,230 |
Mr. Christopher Leland Wolven (1983) Chief Operating Officer | $155,770 |
Mr. Robert E. Mikkelsen (1982) Sec., Treasurer & Chief Financial Officer | $134,620 |
-
What's the price of Item 9 Labs Corp. stock today?
One share of Item 9 Labs Corp. stock can currently be purchased for approximately $0.
-
When is Item 9 Labs Corp.'s next earnings date?
Unfortunately, Item 9 Labs Corp.'s (INLB) next earnings date is currently unknown.
-
Does Item 9 Labs Corp. pay dividends?
No, Item 9 Labs Corp. does not pay dividends.
-
How much money does Item 9 Labs Corp. make?
Item 9 Labs Corp. has a market capitalization of 17.40M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 0.82% to 21.76M US dollars. Item 9 Labs Corp. made a loss 31.18M US dollars in net income (profit) last year or -$0.03 on an earnings per share basis.
-
What is Item 9 Labs Corp.'s stock symbol?
Item 9 Labs Corp. is traded on the OTC under the ticker symbol "INLB".
-
What is Item 9 Labs Corp.'s primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Item 9 Labs Corp.?
Shares of Item 9 Labs Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Item 9 Labs Corp.'s key executives?
Item 9 Labs Corp.'s management team includes the following people:
- Mr. Jeffrey I. Rassas Chief Strategy Officer & Director(age: 62, pay: $196,700)
- Mr. Andrew Douglas Bowden Chief Executive Officer & Director(age: 37, pay: $169,230)
- Mr. Christopher Leland Wolven Chief Operating Officer(age: 42, pay: $155,770)
- Mr. Robert E. Mikkelsen Sec., Treasurer & Chief Financial Officer(age: 43, pay: $134,620)
-
How many employees does Item 9 Labs Corp. have?
As Jul 2024, Item 9 Labs Corp. employs 97 workers.
-
When Item 9 Labs Corp. went public?
Item 9 Labs Corp. is publicly traded company for more then 6 years since IPO on 30 Nov 2018.
-
What is Item 9 Labs Corp.'s official website?
The official website for Item 9 Labs Corp. is item9labscorp.com.
-
Where are Item 9 Labs Corp.'s headquarters?
Item 9 Labs Corp. is headquartered at 2727 North 3rd Street, Phoenix, AZ.
-
How can i contact Item 9 Labs Corp.?
Item 9 Labs Corp.'s mailing address is 2727 North 3rd Street, Phoenix, AZ and company can be reached via phone at 833 867 6337.
Item 9 Labs Corp. company profile:
Item 9 Labs Corp.
item9labscorp.comOTC
97
Drug Manufacturers—Specialty & Generic
Healthcare
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Phoenix, AZ 85004
CIK: 0001500123
:
:
